Page last updated: 2024-08-16

sumatriptan and cilostazol

sumatriptan has been researched along with cilostazol in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (88.89)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Carøe Nordgaard, J; Gammeltoft, S; Kruse, LS; Kruuse, CR	1
Ashina, M; Guo, S; Hansen, EK; Olesen, J	1
Ashina, M; Dunga, BÓÁ; Falkenberg, K; Guo, S; Olesen, J	1
Falkenberg, K; Olesen, J	1
Amin, FM; Ashina, M; Christensen, CE; de Koning, PJH; Ghanizada, H; Khan, S; Larsson, HBW; Olinger, ACR; Younis, S	1
Amin, FM; Ashina, M; Birgens, H; Christensen, CE; Daldrup-Link, H; Fliedner, FP; Khan, S; Kjær, A; Larsson, HBW; Lindberg, U; Olinger, ACR; Tolnai, D; Younis, S	1
Bjerg, HR; Falkenberg, K; Olesen, J	1

Reviews

1 review(s) available for sumatriptan and cilostazol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

6 trial(s) available for sumatriptan and cilostazol

Article	Year
Toward a pragmatic migraine model for drug testing: I. Cilostazol in healthy volunteers. Cephalalgia : an international journal of headache, 2016, Volume: 36, Issue:2 Topics: Adolescent; Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Human Experimentation; Humans; Male; Middle Aged; Migraine Disorders; Sumatriptan; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents; Young Adult	2016
Cilostazol induced migraine does not respond to sumatriptan in a double blind trial. The journal of headache and pain, 2018, Feb-02, Volume: 19, Issue:1 Topics: Adult; Cilostazol; Cross-Over Studies; Cyclic AMP; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Models, Neurological; Phosphodiesterase 3 Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Surveys and Questionnaires; Tetrazoles; Treatment Failure; Young Adult	2018
Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers. The journal of headache and pain, 2018, Aug-17, Volume: 19, Issue:1 Topics: Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Headache; Healthy Volunteers; Humans; Male; Middle Aged; Migraine Disorders; Sumatriptan; Surveys and Questionnaires; Tetrazoles; Vasoconstrictor Agents; Vasodilator Agents; Young Adult	2018
Meningeal contribution to migraine pain: a magnetic resonance angiography study. Brain : a journal of neurology, 2019, 01-01, Volume: 142, Issue:1 Topics: Adolescent; Adult; Carotid Arteries; Cilostazol; Female; Headache; Humans; Magnetic Resonance Angiography; Meningeal Arteries; Middle Aged; Migraine Disorders; Pain Measurement; Sumatriptan; Vasodilation; Young Adult	2019
Investigating macrophage-mediated inflammation in migraine using ultrasmall superparamagnetic iron oxide-enhanced 3T magnetic resonance imaging. Cephalalgia : an international journal of headache, 2019, Volume: 39, Issue:11 Topics: Adult; Animals; Brain; Cilostazol; Dextrans; Female; Humans; Inflammation; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Middle Aged; Migraine Disorders; Neuroimaging; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasodilator Agents	2019
Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients. Cephalalgia : an international journal of headache, 2020, Volume: 40, Issue:8 Topics: Adult; Cilostazol; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasodilator Agents; Young Adult	2020

Other Studies

2 other study(ies) available for sumatriptan and cilostazol

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A. PloS one, 2014, Volume: 9, Issue:9 Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles	2014

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.

PloS one, 2014, Volume: 9, Issue:9

Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles

2014